---
$id: https://graph.org.ai/products/commodity/51161573
$type: Product
source: UNSPSC
code: "51161573"
title: "Pranlukast hydrate"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pranlukast hydrate

**UNSPSC Code**: 51161573
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula 2C27H23N5O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FR702N558K, chemically known as benzamide, n-(4-oxo-2-(2h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-, hydrate (2:1), but more generally known as pranlukast hydrate, which bears US NIH Compound Identifier 5311184. European Medicines Agency schedules pranlukast hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09998MIG. Most nations, for tariff purposes, schedule pranlukast hydrate under HS 29349990. SMILES: C1CCC(CC1)CCCCOC2CCC(CC2)C(=O)NC3CCCC4C3OC(CC4=O)C5[NH]NNN5.C1CCC(CC1)CCCCOC2CCC(CC2)C(=O)NC3CCCC4C3OC(CC4=O)C5[NH]NNN5.O.

